Companies looking for a partner identify their strengths and weaknesses and agree to share promotional efforts.  The owner of the product usually manufactures it and uses the other company`s brand. The profit from sales resulting from a joint promotional effort is distributed according to the effort made by the partners.  Dublin, 28 January 2020 (GLOBE NEWSWIRE) — The report “Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech – Diagnostics 2014-2019” has been added to ResearchAndMarkets.com`s offering. This report provides comprehensive understanding and unprecedented access to co-promotion and co-marketing agreements between world leaders in biopharmacies. The report details the latest co-promotion and co-marketing agreements announced in the pharmaceutical, biotechnology and diagnostic fields. The report has been completely revised and updated and provides details on co-promotion and co-marketing agreements from 2014 to 2019. For pharmaceutical and biotechnology professionals, the report provides a detailed understanding and analysis of how and why companies enter into co-promotion and co-marketing agreements. Most agreements are multi-component, with the licensee retaining the right or opportunity to promote/market the product resulting from research cooperation. There are also many pure co-promotion/marketing agreements, in which the product originator supports a co-promotion/marketing-partner to maximize the presence of products in the market. Understanding the flexibility of a potential partner`s trading conditions provides a critical insight into the trading process compared to what you can expect when negotiating terms. While many small businesses will be looking for details about payment terms, the way payments are triggered is in the details – contract documents provide this information where press releases and databases do not.
This report contains a comprehensive list of all co-promotion and co-marketing agreements announced since 2014 and covered by the “Ongoing Agreements and Alliances” database, including available financial terms and links to online copies of co-promotion and co-marketing documents submitted by companies and their Securities Exchange Commission partners. Contractual documents provide answers to many questions about a potential partner`s flexibility on a number of important issues, many of which will have a significant impact on each party`s ability to deduce a value from the agreement. The first chapters of this report provide guidance on co-promotion and marketing dealmaking and business activities. Chapter 1 contains an introduction to the report, while Chapter 2 contains an analysis of trends in co-promotion and co-marketing, as well as a debate on the benefits of any type of agreement. Chapters 3 and 4 provide an overview of the structure of co-promotion and co-marketing agreements. Each chapter contains numerous case studies to help understand both co-promotion/marketing agreements and multi-component agreements in which co-promotion/marketing plays a role. Chapter 5 provides an overview of key co-promotion and co-marketing agreements since 2014. Deals are listed according to the value of demotom. If the agreement contains a contract published with the SEC, a link allows access to the contract online through the Current Agreements Deals and Alliances database. Chapter 6 provides an overview of the 50 most active biopharmaceutical companies in the fields of co-promotion and co-marketing.